Free Trial

Eledon Pharmaceuticals (ELDN) SEC Filings & 10K Form

Eledon Pharmaceuticals logo
$4.29 -0.05 (-1.15%)
Closing price 02/21/2025 04:00 PM Eastern
Extended Trading
$4.30 +0.00 (+0.12%)
As of 02/21/2025 06:24 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Eledon Pharmaceuticals SEC Filings

DateFilerForm TypeView
02/14/2025
4:34 PM
ARMISTICE CAPITAL, LLC (Filed by)
Eledon Pharmaceuticals, Inc. (Subject)
Eledon Pharmaceuticals (Subject)
Form SCHEDULE 13G/A
02/14/2025
10:22 AM
Eledon Pharmaceuticals, Inc. (Subject)
Eledon Pharmaceuticals (Subject)
Frazier Life Sciences Public Fund, L.P. (Filed by)
Form SCHEDULE 13G/A
01/13/2025
4:30 PM
Eledon Pharmaceuticals, Inc. (Issuer)
Eledon Pharmaceuticals (Issuer)
Kirk Allan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/13/2025
4:30 PM
Eledon Pharmaceuticals, Inc. (Issuer)
Eledon Pharmaceuticals (Issuer)
Robinson James A. Jr. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/13/2025
4:30 PM
Eledon Pharmaceuticals, Inc. (Issuer)
Eledon Pharmaceuticals (Issuer)
Lee June (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/13/2025
4:30 PM
Eledon Pharmaceuticals, Inc. (Issuer)
Eledon Pharmaceuticals (Issuer)
Smith Bryan E. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/13/2025
4:30 PM
Eledon Pharmaceuticals, Inc. (Issuer)
Eledon Pharmaceuticals (Issuer)
Perrin Steven (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/13/2025
4:30 PM
Eledon Pharmaceuticals, Inc. (Issuer)
Eledon Pharmaceuticals (Issuer)
Katkin Keith (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/13/2025
4:30 PM
Eledon Pharmaceuticals, Inc. (Issuer)
Eledon Pharmaceuticals (Issuer)
Little Paul Sean (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/13/2025
4:30 PM
Eledon Pharmaceuticals, Inc. (Issuer)
Eledon Pharmaceuticals (Issuer)
Gros David-Alexandre C (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/13/2025
4:30 PM
Eledon Pharmaceuticals, Inc. (Issuer)
Eledon Pharmaceuticals (Issuer)
McBride John S. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/13/2025
4:30 PM
Eledon Pharmaceuticals, Inc. (Issuer)
Eledon Pharmaceuticals (Issuer)
Hillson Jan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/20/2024
7:00 AM
Eledon Pharmaceuticals, Inc. (Filer)
Eledon Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/22/2024
4:00 PM
Eledon Pharmaceuticals, Inc. (Issuer)
Eledon Pharmaceuticals (Issuer)
Gros David-Alexandre C (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/22/2024
4:00 PM
Eledon Pharmaceuticals, Inc. (Issuer)
Eledon Pharmaceuticals (Issuer)
Smith Bryan E. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/22/2024
4:00 PM
Eledon Pharmaceuticals, Inc. (Issuer)
Eledon Pharmaceuticals (Issuer)
Perrin Steven (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/22/2024
4:00 PM
Eledon Pharmaceuticals, Inc. (Issuer)
Eledon Pharmaceuticals (Issuer)
Little Paul Sean (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/14/2024
3:51 PM
ARMISTICE CAPITAL, LLC (Filed by)
Eledon Pharmaceuticals, Inc. (Subject)
Eledon Pharmaceuticals (Subject)
Form SC 13G/A
11/12/2024
4:00 PM
Eledon Pharmaceuticals, Inc. (Filer)
Eledon Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/05/2024
3:17 PM
Eledon Pharmaceuticals, Inc. (Subject)
Eledon Pharmaceuticals (Subject)
RA CAPITAL MANAGEMENT, L.P. (Filed by)
Form SC 13G
11/05/2024
10:44 AM
Eledon Pharmaceuticals, Inc. (Subject)
Eledon Pharmaceuticals (Subject)
Frazier Life Sciences Public Fund, L.P. (Filed by)
Form SC 13G
10/31/2024
4:52 PM
BIOTECHNOLOGY VALUE FUND II LP (Reporting)
BIOTECHNOLOGY VALUE FUND L P (Reporting)
Biotechnology Value Trading Fund OS LP (Reporting)
BVF GP HOLDINGS LLC (Reporting)
BVF I GP LLC (Reporting)
BVF II GP LLC (Reporting)
BVF INC/IL (Reporting)
BVF PARTNERS L P/IL (Reporting)
BVF Partners OS Ltd. (Reporting)
Eledon Pharmaceuticals, Inc. (Issuer)
Eledon Pharmaceuticals (Issuer)
LAMPERT MARK N (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/31/2024
4:49 PM
BIOTECHNOLOGY VALUE FUND L P (Filed by)
Eledon Pharmaceuticals, Inc. (Subject)
Eledon Pharmaceuticals (Subject)
Form SC 13G/A
10/31/2024
4:50 PM
BIOTECHNOLOGY VALUE FUND L P (Filed by)
Eledon Pharmaceuticals, Inc. (Subject)
Eledon Pharmaceuticals (Subject)
Form SC 13G/A
10/30/2024
5:36 AM
Eledon Pharmaceuticals, Inc. (Filer)
Eledon Pharmaceuticals (Filer)
Form 424B5
10/30/2024
5:24 AM
Eledon Pharmaceuticals, Inc. (Filer)
Eledon Pharmaceuticals (Filer)
Form 424B5
10/29/2024
8:27 PM
Eledon Pharmaceuticals, Inc. (Filer)
Eledon Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/29/2024
7:00 AM
Eledon Pharmaceuticals, Inc. (Filer)
Eledon Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/02/2024
11:15 PM
Eledon Pharmaceuticals, Inc. (Filer)
Eledon Pharmaceuticals (Filer)
Form EFFECT
09/20/2024
4:00 PM
Eledon Pharmaceuticals, Inc. (Filer)
Eledon Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/20/2024
3:16 PM
Eledon Pharmaceuticals, Inc. (Filer)
Eledon Pharmaceuticals (Filer)
Form S-3
Registration statement under Securities Act of 1933  
08/19/2024
3:33 PM
Eledon Pharmaceuticals, Inc. (Filer)
Eledon Pharmaceuticals (Filer)
Form 10-Q/A
08/19/2024
3:36 PM
Eledon Pharmaceuticals, Inc. (Filer)
Eledon Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/19/2024
3:30 PM
Eledon Pharmaceuticals, Inc. (Filer)
Eledon Pharmaceuticals (Filer)
Form 10-K/A
08/14/2024
4:12 PM
Eledon Pharmaceuticals, Inc. (Filer)
Eledon Pharmaceuticals (Filer)
Form NT 10-Q
08/14/2024
4:15 PM
Eledon Pharmaceuticals, Inc. (Filer)
Eledon Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/12/2024
3:30 PM
Eledon Pharmaceuticals, Inc. (Filer)
Eledon Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/10/2024
3:47 PM
Eledon Pharmaceuticals, Inc. (Filer)
Eledon Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/10/2024
3:41 PM
Eledon Pharmaceuticals, Inc. (Filer)
Eledon Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/05/2024
11:15 PM
Eledon Pharmaceuticals, Inc. (Filer)
Eledon Pharmaceuticals (Filer)
Form EFFECT
05/24/2024
3:02 PM
Eledon Pharmaceuticals, Inc. (Filer)
Eledon Pharmaceuticals (Filer)
Form S-3
Registration statement under Securities Act of 1933  
Market down? Do this now. (Ad)

During Trump's first term, his tariffs sent gold prices soaring. Investors who acted early made a fortune. Now, history is repeating itself. Here's the truth: Tariffs create uncertainty. Uncertainty drives investors to gold. And gold prices rise as a result. It's a cycle that's already beginning again—and it's your chance to profit. Why wait? Greed isn't always a bad thing—especially when it comes to protecting and growing your wealth. The smartest investors are already moving their money into gold, and you should too.

Download your Free 2025 Gold Guide Now
05/22/2024
6:36 PM
Eledon Pharmaceuticals, Inc. (Filer)
Eledon Pharmaceuticals (Filer)
Form D
Notice of Exempt Offering of Securities 
05/15/2024
6:00 AM
Eledon Pharmaceuticals, Inc. (Filer)
Eledon Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/13/2024
4:04 PM
BIOTECHNOLOGY VALUE FUND II LP (Reporting)
BIOTECHNOLOGY VALUE FUND L P (Reporting)
Biotechnology Value Trading Fund OS LP (Reporting)
BVF GP HOLDINGS LLC (Reporting)
BVF I GP LLC (Reporting)
BVF II GP LLC (Reporting)
BVF INC/IL (Reporting)
BVF PARTNERS L P/IL (Reporting)
BVF Partners OS Ltd. (Reporting)
Eledon Pharmaceuticals, Inc. (Issuer)
Eledon Pharmaceuticals (Issuer)
LAMPERT MARK N (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/07/2024
6:15 AM
Eledon Pharmaceuticals, Inc. (Filer)
Eledon Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/28/2024
3:30 PM
Eledon Pharmaceuticals, Inc. (Filer)
Eledon Pharmaceuticals (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/28/2024
3:01 PM
Eledon Pharmaceuticals, Inc. (Filer)
Eledon Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:ELDN) was last updated on 2/22/2025 by MarketBeat.com Staff
From Our Partners